115. Technol Cancer Res Treat. 2018 Jan 1;17:1533033818764499. doi:10.1177/1533033818764499.Expression of NK Cell Surface Receptors in Breast Cancer Tissue as Predictors of Resistance to Antineoplastic Treatment.Mariel GC(1), Edith CI(2), Pilar CR(2), Elena GN(3), Humberto RM(4), GuadalupeMM(5), Ignacio MR(4), Alfredo BC(6), Laura PA(7), Adriana AL(8), Felipe JL(8).Author information: (1)1 Instituto de Investigación en Ciencias Biomédicas, Centro Universitario deCiencias de la Salud, Universidad de Guadalajara, Guadalajara, Jalisco, México.(2)2 Centro de Investigación Biomédica del Noreste, Instituto Mexicano del SeguroSocial, Monterrey, Nuevo León, México.(3)3 División de Investigación, Unidad Médica de Alta Especialidad # 34,Instituto Mexicano del Seguro Social. Monterrey, Nuevo León, México.(4)4 Unidad Médica de Alta Especialidad, Centro Médico Nacional de Occidente,Instituto Mexicano del Seguro Social, Guadalajara, Jalisco, México.(5)5 Servicio de Anatomía Patológica, Centro Médico Nacional de Occidente,Instituto Mexicano del Seguro Social, Guadalajara, Jalisco, México.(6)6 Doctorado en Ciencias Biomédicas, Centro Universitario de Ciencias de laSalud, Universidad de Guadalajara, Guadalajara, Jalisco, México.(7)7 Departamento de Fisiología, Centro Universitario de Ciencias de la Salud,Universidad de Guadalajara, Guadalajara, Jalisco, México.(8)8 División de Inmunología, Centro de Investigación Biomédica de Occidente,Instituto Mexicano del Seguro Social, Guadalajara, Jalisco, México.BACKGROUND: Currently, one of the most used strategies for the treatment of newlydiagnosed patients with breast cancer is neoadjuvant chemotherapy based on theapplication of taxanes and anthracyclines. However, despite the high number ofpatients who develop a complete pathological clinical response, resistance andrelapse following this therapy continue to be a clinical challenge. As acomponent of the innate immune system, the cytotoxic function of Natural Killer(NK) cells plays an important role in the elimination of tumor cells. However,the role of NK cells in resistance to systemic therapy in breast cancer remainsunclear. The present project aims to evaluate the gene expression profile ofhuman NK cells in breast cancer tissue resistant to treatment withtaxanes-anthracyclines.METHODS: Biopsies from tumor tissues were obtained from patients with breastcancer without prior treatment. Histopathological analysis and ex vivo exposureto antineoplastic chemotherapeutics were carried out. Alamar blue and lactatedehydrogenase release assays were performed for quantitative analysis of tumorviability. Gene expression profiles from tumor tissues without prior exposure to therapeutic drugs were analyzed by gene expression microarrays and verified bypolymerase chain reaction.RESULTS: A significant decrease in gene expression of cell-surface receptorsrelated to NK cells was observed in tumor samples resistant to antineoplastictreatment compared with those that were sensitive to treatment.CONCLUSION: A decrease in NK cell infiltration into tumor tissue might be apredictive marker for failure of chemotherapeutic treatment in breast cancer.DOI: 10.1177/1533033818764499 PMCID: PMC5882046PMID: 29558872 